Jermasek Douglas 4
4 · Unicycive Therapeutics, Inc. · Filed Aug 30, 2023
Insider Transaction Report
Form 4
Jermasek Douglas
EVP of Corporate Strategy
Transactions
- Award
Stock Options
2023-08-28+1,355,000→ 1,510,000 totalExercise: $0.75Exp: 2033-08-28→ Common Stock (1,355,000 underlying)
Footnotes (1)
- [F1]338,750 of the stock options vest on first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter.